Humoral Immunity in Mice Transplanted with Hematopoietic Stem Cells Derived from Human Umbilical Cord Blood Recapitulates That of Human Infants.

Immunodeficient mice transplanted with human hematopoietic stem cells (HSCs) have been referred to as "Human Immune System" (HIS) mice and are a translational platform for studying human immune responses in vivo. Human HSC sources used in generating HIS mice include fetal liver (FL), umbilical cord blood (CB), and adult bone marrow (BM). Since HSCs from FL, CB, and BM are produced at various stages of human development, we tested whether mice transplanted with these three HSCs differ in their immune responses. We found that compared with CB HSCs or FL HSCs, adult BM HSCs reconstitute the immune system poorly. The resulting HIS mice do not mount an antibody response to Borrelia hermsii infection and as a consequence suffer persistently high levels of bacteremia. While both CB and FL HSCs yield comparable levels of immune reconstitution of HIS mice resulting in robust anti-B. hermsii immune responses, FL HSC-transplanted mice exhibited a discernable difference in their human B cell maturity as identified by an increased frequency of CD10+ immature B cells and relatively smaller lymphoid follicles compared with CB HSC-transplanted mice. Although CB HSC-transplanted mice generated robust antibody responses to B. hermsii and specific protein antigens of B. hermsii, they failed to respond to Salmonella typhi Vi polysaccharide, a classical T cell-independent antigen. This situation resembles that seen in human infants and young children. Therefore, CB HSC-transplanted mice may serve as a translation platform to explore approaches to overcome the impaired antipolysaccharide responses characteristic of human infants.

[1]  C. Chougnet,et al.  Improved multilineage human hematopoietic reconstitution and function in NSGS mice , 2018, PloS one.

[2]  M. Heikenwalder,et al.  Peripheral blood CD34+ cells efficiently engraft human cytokine knock-in mice. , 2016, Blood.

[3]  P. Carmeliet,et al.  Highly proliferative primitive fetal liver hematopoietic stem cells are fueled by oxidative metabolic pathways. , 2015, Stem cell research.

[4]  A. Pollard,et al.  Why the development of effective typhoid control measures requires the use of human challenge studies , 2014, Front. Microbiol..

[5]  M. Levine,et al.  Advancing the management and control of typhoid fever: a review of the historical role of human challenge studies. , 2014, The Journal of infection.

[6]  M. McCarter,et al.  Studies of Lymphocyte Reconstitution in a Humanized Mouse Model Reveal a Requirement of T Cells for Human B Cell Maturation , 2013, The Journal of Immunology.

[7]  T. Manser,et al.  Characteristics of Borrelia hermsii infection in human hematopoietic stem cell-engrafted mice mirror those of human relapsing fever , 2011, Proceedings of the National Academy of Sciences.

[8]  A. Ashkar,et al.  Humanized mice for Salmonella typhi infection: new tools for an old problem , 2011, Virulence.

[9]  T. Rothstein,et al.  Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70− , 2011, The Journal of experimental medicine.

[10]  R. Flavell,et al.  A mouse model for the human pathogen Salmonella typhi. , 2010, Cell host & microbe.

[11]  S. Porwollik,et al.  Humanized nonobese diabetic-scid IL2rγnull mice are susceptible to lethal Salmonella Typhi infection , 2010, Proceedings of the National Academy of Sciences.

[12]  Anne K. Shriner,et al.  IL-7–Dependent B Lymphocytes Are Essential for the Anti-polysaccharide Response and Protective Immunity to Streptococcus pneumoniae , 2010, The Journal of Immunology.

[13]  D. Greiner,et al.  Humanized mouse models to study human diseases , 2010, Current opinion in endocrinology, diabetes, and obesity.

[14]  P. Schneider,et al.  Cracking the BAFF code , 2009, Nature Reviews Immunology.

[15]  S. Colombetti,et al.  IL-7 adjuvant treatment enhances long-term tumor-antigen-specific CD8+ T-cell responses after immunization with recombinant lentivector. , 2009, Blood.

[16]  Yun Hee Cho,et al.  BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact , 2008, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Jacobsen,et al.  FLT3 ligand and not TSLP is the key regulator of IL-7-independent B-1 and B-2 B lymphopoiesis. , 2008, Blood.

[18]  R. Woodland,et al.  Human BLyS Facilitates Engraftment of Human PBL Derived B Cells in Immunodeficient Mice , 2008, PloS one.

[19]  P. Schneider,et al.  TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. , 2008, Cytokine & growth factor reviews.

[20]  K. Alugupalli,et al.  Complement Factor H-Binding Protein, a Putative Virulence Determinant of Borrelia hermsii, Is an Antigenic Target for Protective B1b Lymphocytes1 , 2008, The Journal of Immunology.

[21]  Dale L. Greiner,et al.  Humanized mice in translational biomedical research , 2007, Nature Reviews Immunology.

[22]  Sonia Bahlani,et al.  Immunological and Molecular Analyses of the Borrelia hermsii Factor H and Factor H-Like Protein 1 Binding Protein, FhbA: Demonstration of Its Utility as a Diagnostic Marker and Epidemiological Tool for Tick-Borne Relapsing Fever , 2006, Infection and Immunity.

[23]  L. Herzenberg,et al.  Phenotypically distinct B cell development pathways map to the three B cell lineages in the mouse. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Honjo,et al.  B1b lymphocytes confer T cell-independent long-lasting immunity. , 2004, Immunity.

[25]  I. Mårtensson,et al.  Complementary Signaling through flt3 and Interleukin-7 Receptor α Is Indispensable for Fetal and Adult B Cell Genesis , 2003, The Journal of experimental medicine.

[26]  Jianzhu Chen,et al.  The Resolution of Relapsing Fever Borreliosis Requires IgM and Is Concurrent with Expansion of B1b Lymphocytes1 , 2003, The Journal of Immunology.

[27]  K. Rajewsky,et al.  Homeostasis of Peripheral B Cells in the Absence of B Cell Influx from the Bone Marrow , 2001, The Journal of experimental medicine.

[28]  A. Cumano,et al.  Arrested B Lymphopoiesis and Persistence of Activated B Cells in Adult Interleukin 7−/− Mice , 2001, The Journal of experimental medicine.

[29]  J. Kearney,et al.  B1 cells: similarities and differences with other B cell subsets. , 2001, Current opinion in immunology.

[30]  J. Kearney,et al.  B‐cell subsets and the mature ­preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory” , 2000, Immunological reviews.

[31]  S. Burdach,et al.  Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine , 1995, The Journal of experimental medicine.

[32]  L. Herzenberg,et al.  Characteristics and Development of the Murine B‐lb (Ly‐1 B Sister) Cell Population , 1992, Annals of the New York Academy of Sciences.

[33]  L. Herzenberg,et al.  Differential development of progenitor activity for three B-cell lineages. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Hardy,et al.  Progenitors for Ly-1 B cells are distinct from progenitors for other B cells , 1985, The Journal of experimental medicine.

[35]  A. Ashkar,et al.  Humanized mice are susceptible to Salmonella typhi infection , 2011, Cellular and Molecular Immunology.

[36]  M. Cancro,et al.  The BLyS Family: Toward a Molecular Understanding of B Cell Homeostasis , 2008, Cell Biochemistry and Biophysics.

[37]  D. Greiner,et al.  Humanized SCID mouse models for biomedical research. , 2008, Current topics in microbiology and immunology.

[38]  K. Alugupalli.  A distinct role for B1b lymphocytes in T cell-independent immunity. , 2008, Current topics in microbiology and immunology.

[39]  L. Herzenberg,et al.  De novo development and self-replenishment of B cells. , 1995, International immunology.